RxDoctor Payments Data

Jonathan Paul, MD

Orthopaedic Surgery · Charlotte, NCNPI 1285729061

Payments from drug & device makers

$1,666in general payments, 2019–2025

Across 25 payments — averaging $66.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Peerless Surgical Inc.$1K
  • Smith+Nephew$121
  • Electronic Waveform Lab, Inc.$87
  • Johnson & Johnson$73
  • ERMI LLC$69
  • Bioventus LLC$44
  • plus $157 from 7 others

What the payments were for

  • Food & beverage$68941%
  • Education$97759%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Peerless Surgical Inc.4$1,115
Smith+Nephew1$121
Electronic Waveform Lab, Inc.3$87
Johnson & Johnson2$73
ERMI LLC4$69
Bioventus LLC2$44
Masimo Corporation2$42
Zimmer Biomet1$29
Sanofi-aventis U.S. LLC1$21
Joint Active Systems, Inc.1$19
Kinex Medical Company LLC2$19
Acelrx Pharmaceuticals, Inc.1$15
Ferring Pharmaceuticals Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,666 in reported general payments places this provider in the 30th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$11,215
Medicare patients
28
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam44$67

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →